<DOC>
	<DOCNO>NCT02120664</DOCNO>
	<brief_summary>This study design demonstrate conversion florbetapir ( 18F ) Positron Emission Tomography ( PET ) Standard Uptake Value ratio ( SUVr ) Centiloid unit .</brief_summary>
	<brief_title>Florbetapir Calibration Centiloid Scale</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Cognitively Normal Subjects Males females ≥ 21 ≤ 45 year age Minimental state examination ( MMSE ) ≥ 29 Clinically Diagnosed AD Subject Males females ≥ 50 year age Meet clinical criterion dementia due probable AD MMSE ≥ 16 ≤ 26 Possible AD Subject Males females ≥ 50 year age Meet clinical criterion dementia due possible AD MMSE ≥ 16 ≤ 26 MCI Subject Males females ≥ 60 year age cognitive impairment ( dementia ) MMSE &gt; 24 &lt; 29 At Risk Elderly Subject Cognitively normal male female know ApoE4 carrier ≥ 75 year age MMSE ≥ 27 Have currently diagnosis neurodegenerative disorder AD Have current serious unstable illness could interfere completion study Subject know brain lesion , pathology traumatic brain injury Have receive participated trial investigational medication past 30 day Have radiopharmaceutical imaging treatment procedure within 7 day study image session Females childbearing potential surgically sterile , refrain sexual activity use reliable method contraception</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>